GIP receptor agonism blocks chemotherapy-induced nausea and vomiting

GIP receptor agonism blocks chemotherapy-induced nausea and vomiting

Objective: Nausea and vomiting remain life-threatening obstacles to successful treatment of chronic diseases, despite a cadre of available antiemetic medications. Our inability to effectively control chemotherapy-induced nausea and vomiting (CINV) highlights the need to anatomically, molecularly, an...

Full description

Bibliographic Details
Main Authors:	Tito Borner, Benjamin C. Reiner, Richard C. Crist, C. Daniel Furst, Sarah A. Doebley, Julia G. Halas, Minrong Ai, Ricardo J. Samms, Bart C. De Jonghe, Matthew R. Hayes
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	Molecular Metabolism
Subjects:	Incretin Chemotherapy Vomiting Obesity Diabetes Antiemetic
Online Access:	http://www.sciencedirect.com/science/article/pii/S2212877823000777

Similar Items

Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting
by: Prasan R Bhandari
Published: (2012-01-01)

Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends
by: Kush Gupta, et al.
Published: (2021-01-01)

Postoperative nausea and vomitting – prevention and treatment
by: Ewa Piasek, et al.
Published: (2019-09-01)

Postoperative nausea and vomitting – prevention and treatment
by: Ewa Piasek, et al.
Published: (2019-09-01)

Evaluating the antiemetic administration consistency to prevent chemotherapy-induced nausea and vomiting with the standard guidelines: a prospective observational study
by: Vazin A, et al.
Published: (2017-09-01)

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
by: May MB, et al.
Published: (2016-05-01)

Pediatric related risk factors in acute and delayed chemotherapyinduced nausea and vomiting: multivariate analysis
by: Ariádne Sousa Albuquerque, et al.
Published: (2022-10-01)

Carbamazepine for prevention of chemotherapy-induced nausea and vomiting: a pilot study
by: Thaiana Aragão Santana, et al.

Comparative Study of an Ondansetron and a Ramosetron an Aprepitant in the Control of Nausea and Vomiting in Gynecologinc Cancer Patient with Chemotherapy
by: HANGGOO Yun, et al.
Published: (2013-12-01)

Postdischarge nausea and vomiting (PDNV) in children: A review and observational study
by: Michal Frelich, et al.
Published: (2023-06-01)

Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial
by: Der Sheng Sun, et al.
Published: (2023-05-01)

Prevention of postoperative nausea and vomiting after orthognathic surgery: a scoping review
by: Peng-fei Gao, et al.
Published: (2024-03-01)

An Update in Our Understanding of the Relationships Between Gene Polymorphisms and Chemotherapy-Induced Nausea and Vomiting
by: Jin Y, et al.
Published: (2021-09-01)

Retrospective analysis of real‐world prescribing data for managing cisplatin‐based chemotherapy‐induced nausea and vomiting in China
by: Xia Si, et al.
Published: (2024-03-01)

Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials
by: Senri Yamamoto, et al.
Published: (2021-07-01)

Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice
by: Giulia Notini, et al.
Published: (2024-03-01)

Effect of Adding Midazolam to Dual Prophylaxis for Preventing Postoperative Nausea and Vomiting
by: Jiyoung Lee, et al.
Published: (2021-10-01)

Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk
by: Mototsugu Shimokawa, et al.
Published: (2021-10-01)

Aromatherapy in Palliative Care: A Single-Institute Retrospective Analysis Evaluating the Effect of Lemon Oil Pads against Nausea and Vomiting in Advanced Cancer Patients
by: Gudrun Kreye, et al.
Published: (2022-04-01)

Impact of timing of midazolam administration on incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery: A randomized, double-blinded, controlled study
by: Samar Rafik Amin, et al.
Published: (2022-12-01)

Bromopride, metoclopramide, or ondansetron for the treatment of vomiting in the pediatric emergency department: a randomized controlled trial
by: Matias Epifanio, et al.
Published: (2018-01-01)

Bromopride, metoclopramide, or ondansetron for the treatment of vomiting in the pediatric emergency department: a randomized controlled trial
by: Matias Epifanio, et al.

Construction and effectiveness of vomit-free ward
by: Yao Zhi-Qi, et al.
Published: (2019-11-01)

Risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting
by: Giovana Paula Rezende Simino, et al.
Published: (2020-11-01)

Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients
by: Ghufran salah ahmed, et al.
Published: (2023-05-01)

Cost-effectiveness and efficacy of combined dexamethasone–metoclopramide versus ondansetron in the prevention of postoperative nausea and vomiting in women undergoing myomectomy under spinal anesthesia
by: T A Ogbo, et al.
Published: (2019-01-01)

Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients: A Multicenter Prospective Observational Study
by: Xinjuan Huang, et al.
Published: (2021-01-01)

Prophylaxis of an acute vomiting reflex using orthopedic methods
by: Dmitrieva N.V., et al.
Published: (2011-03-01)

Comparative efficacy of different classes of antiemetic medications for the prevention of nausea and vomiting in cesarean section: A network meta-analysis
by: Zoleykha Asgarlou, et al.
Published: (2023-01-01)

Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old Problem
by: D. S. Baskakov, et al.
Published: (2013-04-01)

Sustaining reductions in postoperative nausea and vomiting after evidence-based practice initiative: A success story
by: Christopher A Smith, et al.
Published: (2017-07-01)

Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study
by: Tomohiko Kimura, et al.
Published: (2024-03-01)

The Balance Between the Effectiveness and Safety for Chemotherapy-Induced Nausea and Vomiting of Different Doses of Olanzapine (10 mg Versus 5 mg): A Systematic Review and Meta-Analysis
by: Dong-Yang Wang, et al.
Published: (2021-09-01)

Role of Prophylactic Dimenhydrinate Versus Ondansetron as an Adjunct to Dexamethasone on Post-Operative Nausea and Vomiting in Laparoscopic Abdominal Procedures
by: Aaifa Khalid Niazi, et al.
Published: (2020-12-01)

Prophylaxis of postoperative nausea and vomiting with combination of ondansetron and dexametasone in urology: Prophylaxis of postoperative nausea and vomiting
by: Gvozdić Branka, et al.
Published: (2016-01-01)

Prevention and Treatment of Postoperative Nausea and Vomiting (PONV): A Review of Current Recommendations and Emerging Therapies
by: Jin Z, et al.
Published: (2020-12-01)

Cyclic Vomiting Syndrome in Children
by: Umberto Raucci, et al.
Published: (2020-11-01)

An Evidence Practice Gap in Antiemetic Prescription with Chemotherapy
by: Chepsy C-Philip, et al.
Published: (2015-10-01)

Palonosetron versus ondansetron for prevention of nausea and vomiting after total abdominal hysterectomy under spinal anesthesia with intrathecal morphine: a double-blind, randomized controlled trial
by: Guilherme Oliveira Campos, et al.
Published: (2019-08-01)

Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section — a randomized control trial
by: Sylvanus Kampo, et al.
Published: (2019-09-01)